Daiichi Sankyo, Roche Melanoma Drug Clears Key Trial Early
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Daiichi Sankyo's drug being developed with Switzerland's Roche has been shown in a study to be highly successful in reducing melanoma deaths